YIH
TERN

Y-Intercept (HK)’s Terns Pharmaceuticals TERN Stock Holding History

Y-Intercept (HK)’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,893
Closed -$1.69M – 2045
2025
Q4 		$1.69M Buy
+41,893
New +$968K 0.04% 699
2025
Q1 		– Sell
-67,002
Closed -$371K – 1604
2024
Q4 		$371K Buy
67,002
+30,610
+84% +$207K 0.02% 862
2024
Q3 		$304K Sell
36,392
-27,071
-43% -$223K 0.02% 1014
2024
Q2 		$432K Buy
+63,463
New +$384K 0.02% 886

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Y-Intercept (HK)'s TERN Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Terns Pharmaceuticals (TERN) in Q1 2026, closing a stake of 41,893 shares — an estimated $1.69M sold.

Y-Intercept (HK) first reported a position in TERN in Q2 2024 and held it in 4 quarters. The position peaked at $1.69M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Terns Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 41,893 Terns Pharmaceuticals shares in Q1 2026, an estimated $1.69M.
  • Y-Intercept (HK) first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Y-Intercept (HK)'s Terns Pharmaceuticals position peaked at $1.69M in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.